Yanda International Hospital
Cirrhosis treatment cost in China depends on disease progression and selected therapeutic methods. A primary diagnostic like biochemical blood analysis ranges from $100 to $100. Major procedures like a liver transplant cost between $92,000 and $158,000, while stem cell treatment for liver cirrhosis runs from $19,500 to $34,000. Expenses fluctuate based on clinic tier, hospitalization length, and location. Patients often save 40-60% compared to US medical costs. Beijing and Guangzhou are the leading cities for specialized care.
Typical Cirrhosis Treatment Costs in China
Bookimed Expert Insight: Patients seeking high-level medical standards should prioritize Class A Level III centers. Yanda International Hospital in Beijing is Joint Commission International (JCI) accredited and offers 3,000 beds. This facility is best for complex cases requiring multidisciplinary expertise and modern technology. With over 9,000 annual operations, it provides top-tier safety for advanced liver interventions. International patients benefit from its 4.5-star rating and comprehensive infrastructure.
| Chiny | Turcja | Austria | |
| Przeszczep wątroby | od $92,000 | od $45,000 | od $320,000 |
| Leczenie marskości wątroby komórkami macierzystymi | od $19,500 | od $12,000 | od $40,000 |
Państwo nie płacą za usługi Bookimed. Ceny leczenia marskości wątroby odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w leczeniu marskości wątroby. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas leczenia marskości wątroby.
Cirrhosis treatment in China integrates standard Western medical protocols with evidence-based Traditional Chinese Medicine. Primary approaches prioritize antiviral therapy for hepatitis B and C. Facilities like Yanda International Hospital employ dual therapy. This combines Western drugs with anti-fibrotic herbs to improve liver function.
Bookimed Expert Insight: While many countries separate traditional and modern medicine, China's Class A level III clinics standardize them. Yanda International Hospital treats 2,500,000 patients annually using this combined model. This high volume allows doctors to refine specific herbal-drug ratios. These protocols are rarely found in purely Western healthcare systems.
Patient Consensus: Patients note that traditional herbs are standard for managing chronic hepatitis symptoms. They also highlight that wait times for liver transplants are often shorter than in Western countries.
Highly recommended hospitals for liver disease and cirrhosis in China include Renji Hospital in Shanghai and West China Hospital in Chengdu. These JCI-accredited and national-level facilities specialize in advanced liver transplantation and hepatobiliary surgery. They maintain high 1-year survival rates for complex pediatric and adult cases.
Bookimed Expert Insight: Yanda International Hospital stands out because it is a Class A level III clinic. This is the highest medical designation possible in China. While many public hospitals serve local volumes, Yanda specifically structures its 3,000 beds for international and adult patients. This focus often speeds up access for those coming from outside mainland China.
Patient Consensus: Patients emphasize that state-run facilities are best for complex transplants. Many recommend hiring a medical coordinator to handle waitlists and the significant language barriers during follow-up care.
Stem cell transplantation for cirrhosis is currently available in China primarily as an experimental therapy. While not a global standard, clinical trials show it is generally safe. The treatment may provide short-term improvements in liver function markers. Long-term effectiveness and complete reversal of scarring remain under investigation.
Bookimed Expert Insight: Yanda International Hospital in Beijing represents a unique trend in Chinese hepatology. It holds JCI accreditation and Class A level III status. These facilities often combine international protocols with traditional approaches. While they serve 2,500,000 patients annually, stem cell procedures are typically positioned as adjunctive care rather than cures. Patients should focus on clinics with 3,000+ beds and high surgical volumes. This infrastructure suggests better management of advanced liver disease complications during experimental protocols.
Patient Consensus: Patients note that while physical fatigue sometimes decreases, follow-up imaging rarely shows structural reversal of liver scarring. Many emphasize that standard medical management like antivirals remains more reliably beneficial than stem cell injections alone.
Clinically proven Traditional Chinese Medicine (TCM) agents for liver fibrosis include Fuzheng Huayu capsules and Compound Biejiaruangan tablets. These formulas inhibit hepatic stellate cell activation and reduce collagen deposition. Studies show they significantly improve liver biopsy pathology and reduce serum fibrosis markers when combined with antiviral therapy.
Bookimed Expert Insight: Success in reversing fibrosis in China often depends on the hospital level rather than just the herbs used. Class A Level III facilities like Yanda International Hospital in Beijing serve 2,500,000 patients annually and use JCI-accredited protocols. These top-tier centers integrate TCM with over 28,500 modern technologies to monitor liver elasticity precisely while administering traditional formulas.
Patient Consensus: Patients note that combining compounds like Fufang Biejia Ruangan with strict diet changes often stabilizes fibrosis scores within 6 months. Many emphasize the need for regular imaging to track actual elasticity improvements safely.